Prediction of short- and medium-term efficacy of biosimilar infliximab therapy. Do trough levels and antidrug antibody levels or clinical and biochemical markers play a more important role?

Gönczi Lóránt and Végh Zsuzsanna and Golovics Petra Anna and Rutka Mariann and Gecse Krisztina Barbara and Bor Renáta and Farkas Klaudia and Szamosi Tamás and Bene László and Gasztonyi Beáta and Kristóf Tünde and Lakatos László and Miheller Pál and Palatka Károly and Papp Mária: Prediction of short- and medium-term efficacy of biosimilar infliximab therapy. Do trough levels and antidrug antibody levels or clinical and biochemical markers play a more important role?
JOURNAL OF CROHNS & COLITIS, 11 (6). pp. 697-705. ISSN 1873-9946 (2017)

[thumbnail of 3140312_Gonczi.pdf] Text
3140312_Gonczi.pdf - Published Version
Restricted access: Registered users only

Download (312kB) | Request a copy
Item Type: Journal Article
Szerzők száma: 25
Journal or Publication Title: JOURNAL OF CROHNS & COLITIS
Date: 2017
Volume: 11
Number: 6
Page Range: pp. 697-705
ISSN: 1873-9946
Faculty/Unit: Faculty of Medicine
Institution: Szegedi Tudományegyetem
Language: English
MTMT rekordazonosító: 3140312
DOI azonosító: https://doi.org/10.1093/ecco-jcc/jjw203
Date Deposited: 2017. Sep. 28. 13:04
Last Modified: 2020. Feb. 14. 11:47
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/12011
Web of Science® Times Cited: 36 View citing articles in Web of Science®

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year